1. Park H, Shin SK, Joo I, Song DS, Jang JW, Park JW. 2020; Mar. 9. Systematic review with meta-analysis: low-level alcohol consumption and the risk of liver cancer. Gut Liver. [Epub ahead of print]. DOI:
10.5009/gnl19163. PMID:
32135583.
Article
2. Bagnardi V, Rota M, Botteri E, et al. 2015; Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 112:580–593. DOI:
10.1038/bjc.2014.579. PMID:
25422909. PMCID:
PMC4453639.
Article
3. Wang YT, Gou YW, Jin WW, Xiao M, Fang HY. 2016; Association between alcohol intake and the risk of pancreatic cancer: a dose-response meta-analysis of cohort studies. BMC Cancer. 16:212. DOI:
10.1186/s12885-016-2241-1. PMID:
26968702. PMCID:
PMC4788838.
Article
5. Kawano Y. 2010; Physio-pathological effects of alcohol on the cardiovascular system: its role in hypertension and cardiovascular disease. Hypertens Res. 33:181–191. DOI:
10.1038/hr.2009.226. PMID:
20075936.
Article
6. Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J. QalyDays Study Group. 2018; Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study. Lancet Public Health. 3:e124–e132. DOI:
10.1016/S2468-2667(18)30022-7. PMID:
29475810.
Article
15. Wood AM, Kaptoge S, Butterworth AS, et al. 2018; Risk thresholds for alcohol consumption: combined analysis of individual- participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 391:1513–1523. DOI:
10.1016/S0140-6736(18)30134-X. PMID:
29676281. PMCID:
PMC5899998.
16. Becker U, Deis A, Sørensen TI, et al. 1996; Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 23:1025–1029. DOI:
10.1002/hep.510230513. PMID:
8621128.
Article
19. Park SH, Plank LD, Suk KT, et al. 2020; Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017. Clin Mol Hepatol. 26:209–215. DOI:
10.3350/cmh.2019.0065. PMID:
31679316. PMCID:
PMC7160351.
Article
20. Lee YS, Seo YS, Kim JH, et al. 2018; Can more aggressive treatment improve prognosis in patients with hepatocellular carcinoma? A direct comparison of the Hong Kong liver cancer and Barcelona clinic liver cancer algorithms. Gut Liver. 12:94–101. DOI:
10.5009/gnl17040. PMID:
28873509. PMCID:
PMC5753690.
Article